Skip to content
Menu

Beam Therapeutics Inc. BEAM

Full chart Compare
Set alert

Price alert · BEAM

All alert types
20.90 USD -0.04 (-0.19%)

Regular-session close

21.66 +0.76 +3.65%

After hours · Nov 20, 6:53 PM ET

20.54 Day range 22.10
20.60 52-week range 37.92
YTD
-24.60%
1 year
+1.46%

Revenue & Expenses

Revenue Profit Costs
Other Income$303.70MOther Operating Income$22.29MGross Profit$117.45MNet Loss$79.99MCost of Revenue$22.29MExpenses$523.44MSelling, General & Admin$113.82MResearch & Development$409.62MRevenue$139.74M

Latest period ending Dec 31, 2025 · select a line to chart its full history

BEAM annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
139.74M63.52M377.71M60.92M51.84M
139.74M63.52M377.71M60.92M51.84M
-383.69M-415.57M-176.49M-338.48M-392.46M
-79.99M-376.74M-132.53M-289.09M-370.64M
-0.81-4.58-1.72-4.13-5.77
BEAM annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
301.62M290.11M444.61M245.52M572.74M
1.48B1.10B1.46B1.34B1.47B
242.82M370.28M478.38M608.24M647.72M
154.12M161.43M172.69M179.00M147.64M
1.24B733.54M981.33M733.47M826.74M
BEAM annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-345.10M-347.25M-149.19M22.53M-66.27M
-121.44M185.01M71.84M-461.34M-294.14M
478.05M7.74M276.45M111.59M756.14M
-14.95M-8.95M-33.73M-48.95M-46.81M
11.51M-154.50M199.09M-327.22M395.73M